MAPT and frontotemporal dementia: In animal experiments, glycoprotein non-metastatic melanoma protein B (GPNMB) levels were significantly elevated in the cerebrospinal fluid of FTD-GRN mice, whereas no such increase was observed in MAPT or C9orf72 mice.